This is the authors' abstract. We don't add key points for this paper.
The skin lesion erythema migrans (EM) is the first clinical sign of Lyme disease, an infection due to the tick-transmitted bacterium Borrelia burgdorferi ( Bb ). Previously, we used scRNA-Seq to characterize the cutaneous immune response in the EM lesion, focusing on B cells. Here, with an expanded sample size, we profiled T cell responses in EM lesions compared to autologous uninvolved skin. In addition to CD4 + T cell subsets known to be abundant in the EM, we identified clonal expansion of CD8 + GZMK + IFNG + T cells that exhibited significant differential expression of interferon-regulated genes. This subset included IFNG + cells with low cytotoxic gene expression, which may promote inflammation. While FOXP3 + regulatory T cells were also increased in EM, they exhibited little IL10 expression. In contrast, a CD4 + FOXP3 - tissue-resident T cell subset contained the largest population of cells with IL10 expression. Fibroblasts, endothelial cells, and pericytes were the principal cells that significantly differentially expressed key T cell-recruiting chemokines. These studies represent the first comprehensive interrogation of the cutaneous T cell response to Bb infection using single cell transcriptomics with adaptive immune receptor sequencing, providing insight into the skin barrier defense and orchestration of the immune response to this vector-borne pathogen.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Aron et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: